Price cuts for 99 medicines Philippines

Wednesday, November 11, 2009

PRICES FOR 99 branded medicines are expected to be cut substantially next month as part of moves to implement the Cheaper Medicines Act of 2008.

Price caps will be mandated for five of the essential drugs after voluntary offers by the industry were found compliant only with respect to 16, the Health department said.
A draft executive order (EO) will be submitted by the department on or before Friday and President Gloria Macapagal-Arroyo is expected to sign it before she leaves for Washington next week, Executive Secretary Eduardo R. Ermita said.
Figuring in the 31 medicines covered by the “add-on” list, 99 branded products will have their prices cut on August 15, officials said.
Robert Louie P. So, program manager of the Health department’s National Drug Policy unit, declined to identify the specific drugs.
The 21 essential drugs are: anti-hypertensives amlodipine, telmisartan, irbesartan, clopidogrel, and atorvastatin; antidiabetic gliclazide; antibiotics piperacillin/tazobactam, ciprofloxacin, azithromycin, metronidazole, and co-amoxiclav; and the anticancer medicines bleomycin, carboplatin, cisplatin, cyclophosphamide, cytarabine, doxorubicin, etoposide, mercaptopurine, methotrexate, and mesna.


Post a Comment